[
    [
        {
            "time": "2019-02-28",
            "original_text": "Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for February 28, 2019",
            "features": {
                "keywords": [
                    "Astrazeneca",
                    "Ex-Dividend",
                    "Scheduled"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 2,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 1,
                "Headline_Structure": 6,
                "Source_Recency": 1
            }
        },
        {
            "time": "2019-02-28",
            "original_text": "Perrigo Company (PRGO) Ex-Dividend Date Scheduled for February 28, 2019",
            "features": {
                "keywords": [
                    "Perrigo",
                    "Ex-Dividend",
                    "Scheduled"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 2,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 1,
                "Headline_Structure": 6,
                "Source_Recency": 1
            }
        },
        {
            "time": "2019-02-27",
            "original_text": "IUSG, PFE, USB, ISRG: ETF Inflow Alert",
            "features": {
                "keywords": [
                    "ETF",
                    "Inflow",
                    "Alert"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2019-02-26",
            "original_text": "The patent system ‘keeps American drug prices so high’",
            "features": {
                "keywords": [
                    "patent",
                    "system",
                    "drug",
                    "prices"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 2,
                "Headline_Structure": 8,
                "Source_Recency": 1
            }
        },
        {
            "time": "2019-02-25",
            "original_text": "Big Pharma's Showdown With Congress Over Drug Pricing: What It Really Means for You",
            "features": {
                "keywords": [
                    "Big",
                    "Pharma",
                    "Congress",
                    "Drug",
                    "Pricing"
                ],
                "sentiment_score": -0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 10,
                "Time_Proximity": 3,
                "Headline_Structure": 9,
                "Source_Recency": 2
            }
        }
    ]
]